Elpiscience is a clinical-stage biopharmaceutical company dedicated to developing life-changing immuno-oncology therapies for cancer patients worldwide. The company’s innovative approach is focused on targeting tumor microenvironment to identify effective mechanisms to kill cancer. A pipeline of novel molecules has been developed using its proprietary platforms. Through internal R&D expertise and partnerships with global biopharmaceutical companies, Elpiscience endeavors to advance the programs with breakthrough value into clinic use. To learn more, please visit www.elpiscience.com.

Jumo Health (www.jumohealth.com) creates tailored, highly empathetic educational resources to engage, enroll and retain patients for clinical studies. Covering 24 therapeutic areas and 180 health topics in 120 languages, our human-centered solutions are developed in close collaboration with 150 patient and caretaker communities to incorporate their needs, motivations and concerns, as well as the effects of social determinants of health on their decision making. By creating accessible, relevant and impactful communications for sponsors and sites, Jumo Health empowers patients to take charge of their health, removes barriers to clinical trial participation, and ultimately contributes to better outcomes. For more information, please visit https://jumohealth.com/

Empath Labs designs and implements pediatric patient engagement programs that drive adherence and retention, strengthen brand relationships, and support patients through their care journey. You can spot us at conferences with our interactive Clinical Companions, specially designed to provide comfort and education to children and teens in clinical trials. For more information, go to www.empathlabs.com

Serán is a sci­ence-based CDMO that specializes in a variety of drug delivery and formu­lation strategies suited to optimizing bioavailability. Serán’s experienced formulation team works with customers to identify an appropriate formulation strategy to meet each program’s unique needs with a material-sparing approach. Serán provides capsules, tablets, multi-particulates, and PiB formulations. To learn more, please visit https://www.seranbio.com/

At RPK Medical, we stand out as your long-term partner, experts in crafting tailor-made solutions in the medical device sector. Our commitment goes beyond providing solutions – we aim to transform lives for the better. We prioritize listening to you, understanding your unique needs, and tailoring solutions that go beyond springs, stamping & bending or assemblies with precision and reliability. • 50 years of expertise in creating precision customized parts for security applications • Glocal service: thinking globally, acting locally. Factories in Europe, North America and Asia • Engineering excellence, tailor made for your needs • Customized cleaning and packaging (Clean rooms in Europe, North America and Asia) • A sustainable project, your long-term partner from design to manufacturing. For more information, visit https://rpk-medical.com/en or https://rpk-global.com/medical

Founded in 2012, Slingshot Biosciences is a fast growing life sciences company with a platform technology and paradigm-shifting mission to make synthetic cells the gold standard for all cell-based applications—including diagnostics, adoptive cell therapy development and instrument calibration. Learn more at www.slingshotbio.com

Noble Life Sciences description : Noble is a preclinical CRO based in Sykesville, Maryland, offering GLP and non-GLP services, including safety and efficacy testing, for the development of novel therapeutics. Our Oncology team has deep experience designing and implementing a variety of animal models to characterize oncology drug candidates for efficacy, pharmacodynamics, pharmacokinetics, toxicity, and bioavailability.

Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer. By combining expertise in immunology and immunotherapy, Elicio is engineering investigational AMP immunotherapies intended to precisely target and fully engage the lymph nodes.  ELI-002, a structurally novel investigational AMP therapeutic immunotherapy targeting mutant KRAS-driven solid tumors, is currently in a Phase 2 trial in patients with high relapse risk mKRAS-driven pancreatic cancer.

Cytovation is a clinical-stage immuno-oncology biotech focused on the development of CyPep- 1, a first-in-class synthetic peptide that drives a systemic and cancer-specific immune response. CyPep-1 has a dual mode of action that includes (1) inhibition of the Wnt/beta-catenin oncogenic pathway, and (2) disruption of cancer cell membranes and exposure of neoantigens to the tumor microenvironment. Building on positive data from a 55-patient Ph 1/2a study, Cytovation is focusing on beta-catenin-driven cancers with metastasis to the liver, an area of very high unmet need.

Phastar is a leading, award-winning, specialist Biometrics CRO that provides statistical consulting, analysis, reporting, data management and data science services to small and large biotechnology, pharmaceutical and medical device companies across the world. We leverage collaboration, technology, clinical data, and our worldwide presence to optimize decision-making for safety, quality, and efficiency. With 15 offices worldwide, our number one priority is ensuring on-time, quality work and assisting our customers in optimizing their clinical research. For more information, please visit https://phastar.com/

CellGenix and Albumedix, now part of Sartorius -- a trusted partner of the life science and biopharmaceutical industry -- offer developers high-quality, consistent, and dependable raw materials. Join us and discover more about our cytokine, media, and recombinant albumin solutions, and how they can drive your project forward.

As a CLIA/CAP accredited laboratory, we support translational research and clinical trials. We leverage advanced laboratory technologies to provide diagnostic and discovery modules including histology, spatial biology, digital pathology, image analysis, pathology central review, liquid biopsy, proteomics, genomics, and biomarker discovery and validation.